252
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease

ORCID Icon, , , , , , , ORCID Icon & ORCID Icon show all
Pages 2623-2633 | Received 10 Aug 2022, Accepted 30 Sep 2022, Published online: 17 Oct 2022

References

  • Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720–735. doi:10.1183/09031936.05.00034905
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.00035205
  • Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511–522. doi:10.1183/09031936.05.00035005
  • Culver BH, Graham BL, Coates AL, et al. Recommendations for a standardized pulmonary function report. An official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2017;196(11):1463–1472. doi:10.1164/rccm.201710-1981ST
  • Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016. doi:10.1183/13993003.00016-2016
  • Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi:10.1164/rccm.201908-1590ST
  • Reddel HK, Bacharier LB, Bateman ED, et al. Global initiative for asthma strategy 2021: executive summary and rationale for key changes. Eur Respir J. 2022;59(1):2102730. doi:10.1183/13993003.02730-2021
  • Brand PL, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax. 1992;47(6):429–436. doi:10.1136/thx.47.6.429
  • Ward H, Cooper BG, Miller MR. Improved criterion for assessing lung function reversibility. Chest. 2015;148(4):877–886. doi:10.1378/chest.14-2413
  • Quanjer PH, Ruppel GL, Langhammer A, et al. Bronchodilator response in FVC is larger and more relevant than in FEV(1) in severe airflow obstruction. Chest. 2017;151(5):1088–1098. doi:10.1016/j.chest.2016.12.017
  • Tan WC, Vollmer WM, Lamprecht B, et al. Worldwide patterns of bronchodilator responsiveness: results from the burden of obstructive lung disease study. Thorax. 2012;67(8):718–726. doi:10.1136/thoraxjnl-2011-201445
  • Burity EF, Pereira CA, Jones MH, Sayão LB, Andrade AD, Britto MC. Bronchodilator response cut-off points and FEV 0.75 reference values for spirometry in preschoolers. J brasileiro de pneumologia. 2016;42(5):326–332. doi:10.1590/s1806-37562015000000216
  • Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1). doi:10.1183/13993003.01499-2021
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
  • Gao Y, Han J, Jiang L, et al. Guidelines for pulmonary function tests (Part IV) -bronchodilator reversibility testing. Chin J Tuberc Respir Dis. 2014;37(09):655–658.
  • Pulmonary Function Group RDSoCMA. Guidelines for pulmonary function tests (Part II)- spirometer examination. Chin J Tuberc Respir Dis. 2014;37(07):481–486.
  • Pulmonary Function Group RDSoCMA. Guidelines for Pulmonary Function Tests (Part I) - Overview and general requirements. Chin J Tuberc Respir Dis. 2014;37(06):402–405.
  • Bhatt SP, Fortis S, Bodduluri S. New guidelines for bronchodilator responsiveness in COPD: a test in search of a use. Am J Respir Crit Care Med. 2022. doi:10.1164/rccm.202203-0458LE
  • Hanania NA, Sharafkhaneh A, Celli B, et al. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011;12(1):6. doi:10.1186/1465-9921-12-6
  • Barjaktarevic IZ, Buhr RG, Wang X, et al. Clinical significance of bronchodilator responsiveness evaluated by forced vital capacity in COPD: SPIROMICS cohort analysis. Int J Chron Obstruct Pulmon Dis. 2019;14:2927–2938. doi:10.2147/copd.S220164
  • Koga T, Kamimura T, Oshita Y, et al. Determinants of bronchodilator responsiveness in patients with controlled asthma. J Asthma. 2006;43(1):71–74. doi:10.1080/02770900500448662
  • Ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med. 2001;164(5):744–748. doi:10.1164/ajrccm.164.5.2011026
  • Little SA, Sproule MW, Cowan MD, et al. High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity. Thorax. 2002;57(3):247–253. doi:10.1136/thorax.57.3.247
  • Han MK, Wise R, Mumford J, et al. Prevalence and clinical correlates of bronchoreversibility in severe emphysema. Eur Respir J. 2010;35(5):1048–1056. doi:10.1183/09031936.00052509
  • Chen C, Jian W, Gao Y, Xie Y, Song Y, Zheng J. Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness. Int J Chron Obstruct Pulmon Dis. 2016;11:2519–2526. doi:10.2147/copd.S110021
  • Walker PP, Calverley PM. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease. Copd. 2008;5(3):147–152. doi:10.1080/15412550802092928
  • Lee JS, Huh JW, Chae EJ, et al. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease. Clin Physiol Funct Imaging. 2012;32(1):12–18. doi:10.1111/j.1475-097X.2011.01046.x
  • Hansen JE, Dilektasli AG, Porszasz J, et al. A new bronchodilator response grading strategy identifies distinct patient populations. Ann Am Thorac Soc. 2019;16(12):1504–1517. doi:10.1513/AnnalsATS.201901-030OC
  • Fortis S, Comellas A, Make BJ, et al. Combined forced expiratory volume in 1 second and forced vital capacity bronchodilator response, exacerbations, and mortality in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2019;16(7):826–835. doi:10.1513/AnnalsATS.201809-601OC
  • Ferrer Galván M, Javier Alvarez Gutiérrez F, Romero Falcón A, Romero B, Sáez A, Medina Gallardo JF. Is the bronchodilator test an useful tool to measure asthma control? Respir Med. 2017;126:26–31. doi:10.1016/j.rmed.2017.03.008
  • Janson C, Malinovschi A, Amaral AFS, et al. Bronchodilator reversibility in asthma and COPD: findings from three large population studies. Eur Respir J. 2019;54(3):1900561. doi:10.1183/13993003.00561-2019
  • Ioachimescu OC, Ramos JA, Hoffman M, McCarthy K, Stoller JK. Assessing bronchodilator response by changes in per cent predicted forced expiratory volume in one second. J Investig Med. 2021;69(5):1027–1034. doi:10.1136/jim-2020-001663